Fast Company June 14, 2020
Ruth Reader

Machine learning can speed up the creation of new drugs and unlock the mysteries of major diseases, says Insitro CEO Daphne Koller.

Daphne Koller is best known as the cofounder of Coursera, the open database for online learning that launched in 2012. But before her work on Coursera, she was doing something much different. In 2000, Koller started working on applying machine learning to biomedical datasets to understand gene activity across cancer types. She put that work on hold to nurture Coursera, which took many more years than she initially thought it would. She didn’t return to biology until 2016 when she joined Alphabet’s life science research and development arm Calico.

Two years later, Koller started...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
How to use LLMs to lose your competitors: A mixology for enterprise leaders
General Catalyst Reportedly Raises Nearly $6 Billion for Tech Firms
What do employees really want out of generative AI?
Make gen AI work: The landscape, SLMs vs. LLMs, cost and more
AI Supercharges Fentanyl Production And Distribution, Study Finds

Share This Article